 | | Wednesday, July 25, 2012 |  | | | |  |
The DTCC Consortium:
In an effort to help researchers develop better models of human disease, Charles River has joined UC Davis, the Toronto Centre for Phenogenomics and Children's Hospital Oakland Research Institute to establish the DTCC Consortium. The DTCC is assembling a repository of knockout mouse lines and phenotype data as part of the NIH's Knockout Mouse Project (KOMP2). The research community can access a subset of mutant mice and associated resources for follow-up research or in-depth evaluation in collaboration with the DTCC. Model analysis services and phenotyping platforms are also available.
Learn more about these resources at www.criver.com/info/dtcc. | 
More Top News | 
Fast and Simple RNA Sequencing by Invitrogen:
The Ion PGM™ Sequencer puts RNA-Seq within reach of any lab, providing a fast, affordable, easy-to-use system for expression analysis of miRNA and mRNA. Offering better sensitivity, the Ion PGM™ Sequencer generates data superior to that obtained using microarrays-for a comparable price.
Please click here for more information. | | 
More Featured News | 
SafeBridge Consultants, Inc. announces two Potent Compound Safety Training offerings (may be taken separately or consecutively)
The SafeBridge original Potent Compound Safety "Boot Camp"® (Boot Camp I) is a comprehensive two-day course in pharmaceutical potent compound safety focused on training EH&S and related professionals in critical technical concepts and proactive safety programs in pharmaceutical industrial hygiene, occupational and environmental toxicology, analytical chemistry, and risk communication.
The SafeBridge Advanced Concepts to Support Drug Development of Potent Compounds from R&D through Manufacturing (Boot Camp II) is a one-day advanced course focused on case studies and problem-solving to address potent compound safety issues in discovery, development, contract manufacturing and commercialization.
COURSE SEATING IS LIMITED AND USUALLY SELLS OUT!
Oct 23 - 25, 2012 Chicago, IL (USA)
Nov 6 - 8, 2012 Liverpool, England (UK)
Contact: Susan Custer: susan.custer@safebridge.com or 650-961-4820 x 231 or www.safebridge.com | |  • Pharm Country (Berkeley Heights, New Jersey)
Celgene
Senior Director, Aggregate Safety Reporting
Participate in PSRM meetings to ensure current awareness of key safety topics. Develop & maintain key processes that permit the generation of PSURs, DSURs & RMPs. Liaise with Lead Product Safety MDs in development of strategy for PSUR/DSUR/RMP.
• Biotech Beach (Santa Monica, California)
Astellas Pharma US
Maintenance Technician
Will perform scheduled Preventive Maintenance and Corrective Maintenance on equipment and systems in the manufacturing, laboratories, general facility, utility and office areas. Coordinate maintenance activities with area supervisors. Order spare parts, replacement parts, solicit vendor quotes and oversee vendor/contractor work within your area of responsibility.
• BioMidwest (Saint Charles, Missouri)
EMD Group
Supervisor Quality Management
Responsible for the Supplier Quality Managment activities at the St. Charles, MO site. The Quality Supervisor will rate suppliers, conduct supplier audits, drive supplier's quality improvement, perform supplier corrective action verification activities, and assess new suppliers.
• Biotech Bay (Hayward, California)
MedImmune, LLC
Scientist II/Senior Scientist
Support and contribute to the overall strategic planning and prioritization of biomarker studies within and across TM Analytical teams. Coordinate and lead staff when delegated by the group head to deliver scientific data and supporting technology that facilitates the development of pipeline candidate drugs (vaccines and biologics) and epidemiologic studies.
• Genetown (Waltham, Massachusetts)
AstraZeneca Pharmaceuticals LP
Discovery Project Toxicologist
Responsible and accountable for delivering toxicological support to specific allocated projects within the early infection and oncology iMed portfolio based in Boston. Represents GSA in cross-functional discovery project teams for multiple drug projects.
Get Noticed! Add your resume to the BioSpace Career Center!
See more than 5,000 job postings in the BioSpace Career Center! | | 
2012 Pharm Country Career Fair
Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area.
Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)
Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.
Job seekers may register here.
• Pharm Country Career Fair, Bridgewater, NJ September 13, 2012
• Biotech Beach Career Fair, San Diego, CA September 20, 2012
• Biotech Bay Career Fair, Burlingame, CA October 3, 2012
• BioCapital Career Fair, Bethesda, MD October 9, 2012
• BioMidwest Career Fair, Lincolnshire, IL October 22, 2012
• Bio NC Career Fair, Durham, NC October 25, 2012
• Genetown Career Fair, Cambridge, MA November 5, 2012
More information about BioSpace's Career Fairs
BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services | | 
The Global Pharmaceutical Fine Chemicals Market Outlook to 2015
• Evaluate the PFC market in terms of regulatory environment, demand/supply dynamics, market size and structure.
• Gain up-to-date information regarding the deals and alliances in the PFC industry and how they affect the major players in this market.
• Understand the basic PFC manufacturing processes and the raw materials used in their production.
Click Here for More Information. | 
Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing
This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.
Request Now! | 
Alnylam Pharmaceuticals
300 Third Street
Cambridge, Massachusetts 02142 U.S.A.
Phone: 617-551-8200 Fax: 617-551-8103
Alnylam Pharmaceuticals (NASDAQ: ALNY) is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is leading the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases, including ALN-TTR for the treatment of transthyretin-mediated amyloidosis (ATTR), ALN-PCS for the treatment of severe hypercholesterolemia, ALN-HPN for the treatment of refractory anemia, and ALN-APC for the treatment of hemophilia.
More Company Profiles | | 
 | FREE Subscription to Life Science Leader
Life Science Leader is designed to not only inform readers of best practices that are occurring throughout the life cycle of the industry, but motivate them to implement those best practices in their own businesses. |
| 
Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship
BioSpace Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
| BioSpace Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217 |
Send questions and comments to the BioSpace News Beat Team.
Editor & Publisher: Lana Ho
Editorial & Production Staff: Maysa Darwish, Tammy Liu
BioSpace.com - Life. Science. Community. | | 
• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. | |  | |  |  | |
No comments:
Post a Comment